Myocardial regeneration strategy using Wharton’s jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study-Reference-Cited by-同舟云学术

Myocardial regeneration strategy using Wharton’s jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study

Published:2015 Issue: Volume:2 Page:100-107
ISSN:1734-9338
Container-title:Advances in Interventional Cardiology
language:
Short-container-title:pwki

Author:

Musialek Piotr,Mazurek Adam,Jarocha Danuta,Tekieli Lukasz,Szot Wojciech,Kostkiewicz Magdalena,Banys R. Pawel,Urbanczyk Malgorzata,Kadzielski Andrzej,Trystula Mariusz,Kijowski Jacek,Zmudka Krzysztof,Podolec Piotr,Majka Marcin

Publisher

Termedia Sp. z.o.o.

Subject

Cardiology and Cardiovascular Medicine

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective randomized controlled study of multi-intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure and reduced ejection fraction (PRIME-HFrEF) trial: Rationale and design;Contemporary Clinical Trials Communications;2024-10

2. Stem cell and exosome therapies for regenerating damaged myocardium in heart failure;Life Sciences;2024-08

3. Application of mesenchymal stem cells derived from the umbilical cord or Wharton’s jelly and their extracellular vesicles in the treatment of various diseases;Tissue and Cell;2024-08

4. Stem Cell Therapy for Myocardial Infarction and Heart Failure: A Comprehensive Systematic Review and Critical Analysis;Cureus;2024-05-01

5. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing;Physiological Reviews;2024-04-01